SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dino's Bar & Grill

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Goose94 who wrote (2590)9/18/2013 7:23:45 PM
From: Goose94Read Replies (2) of 202704
 
Patient Home Monitoring (PHM-V) TOP PICK from Jerome Hass, Partner, Lightwater Partners on BNN.ca Wednesday Sept 18 @ 1800ET

PHM is a small, profitable U.S. healthcare services that operates in a lucrative niche. PHM helps the patient monitor their health by an easy in-home blood test. Performing the test at-home rather than in a hospital under medical supervision is a significant cost savings for medicare.

There are four million patients under medicare that could be eligible for this program; so far only 10 percent of these patients have at-home testing.

The stock is a play on demographics in that patients are living longer but also more inclined to suffer cardiac and diabetic issues.

The company’s representatives speak to each patient on a weekly basis. Because they own this relationship, there is potential to cross-sell other complimentary services. Hence the stock can also be considered a healthcare roll-up / consolidation player.

Two executive members of PHM bought large blocks of the stock at $0.21, a premium at the time when it was trading at $0.17.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext